arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

download Export Data

Healthcare Realty Trust Inc

$19.97 ▼ -0.25 (-1.21%) at close

18 Visible periods

34 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Poor

Bearish

auto_awesome

Analytical Summary

Healthcare Realty Trust Inc faces fundamental challenges with weakness in Profit Margin (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $7.0B

Dividend Yield 5.51%

Revenue Growth -6.9% ↘

Op. Margin None

ROIC None

FCF / Share None

Trailing P/E —

Price / Book 1.5x

FCF Yield —

Debt / Equity 0.85

info Valuation on last close. End-of-day price, Aug 7, 2026.

18-Year Financial Trajectory

Annual

Metric Value Trend Year over Year Percentile

Revenue Total top-line sales

$1.18B

↓ -6.9% —

Net Income Profit after all expenses

$-246.07M

↑ +62.4% —

Operating Margin Operating profit as % of sales

22.1%

↓ -4.6% —

Long-Term Debt Long-term obligations

$3.91B

↓ -16.1% —

trending_up

Bullish Indicators

No bullish signals detected.

warning

Bearish Risks

Profit Margin (%)Profit Margin (%) is in the bottom quartile

Health Breakdown

Profitability

Returns

Financial Health →

Dividend History

Dividend / share · sourced from SEC filings

$1.10 Latest / share

-11.3% YoY

-0.4% 12-yr CAGR

$1.16

FY 2014

$1.17

FY 2015

$1.19

FY 2016

$1.21

FY 2017

$1.23

FY 2018

$1.25

FY 2019

$1.27

FY 2020

$1.21

FY 2021

$1.24

FY 2022

$1.24

FY 2023

$1.24

FY 2024

$1.10

FY 2025

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 7 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Dec 31, 2009 10-K ↗	FY 2008 Dec 31, 2008 10-K ↗
Revenue Growth YoY (%)	-6.9% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-238%)	-5.6% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-212%)	44.1% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+782%)	74.4% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+1388%)	-27.6% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-653%)	6.8% Fair ↓ Fair Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+36%)	-0.6% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-113%)	13.4% Good ↓ Good Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+169%)	33.2% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+564%)	14.1% Good ↑ Good Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+183%)	8.7% Fair ↓ Fair Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+74%)	15.5% Good ↓ Good Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+210%)	8.1% Fair ↓ Fair Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+63%)	8.4% Fair ↓ Fair Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+67%)	35.1% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+603%)	56.8% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+1037%)	—	—
EPS Growth YoY (%)	60.8% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	-144.6% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	N/M	-66.7% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	87.5% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	60.0% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	-85.6% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	197.1% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	2.9% Caution ↓ Caution Declining Year-over-year change in earnings per share Optimal: > 10%	30.8% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	-31.6% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	81.0% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	N/M	N/M	N/M	77.3% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	—	—
Net Income Growth YoY (%)	62.4% Excellent ↑ Excellent Improving Year-over-year change in net income	-135.2% Weak ↓ Weak Declining Year-over-year change in net income	N/M	-38.6% Weak ↓ Weak Declining Year-over-year change in net income	26.7% Excellent ↓ Excellent Declining Year-over-year change in net income	74.5% Excellent ↑ Excellent Improving Year-over-year change in net income	-85.9% Weak ↓ Weak Declining Year-over-year change in net income	234.0% Excellent ↑ Excellent Improving Year-over-year change in net income	39.2% Excellent ↑ Excellent Improving Year-over-year change in net income	39.4% Excellent ↑ Excellent Improving Year-over-year change in net income	-27.4% Weak Weak Year-over-year change in net income	87.0% Excellent Excellent Year-over-year change in net income	N/M	N/M	N/M	68.5% Excellent Excellent Year-over-year change in net income	—	—
FCF Growth YoY (%) N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Revenue CAGR 3Y (%)	8.2% Fair ↓ Fair Declining Compound annual revenue growth over 3 years	33.4% Excellent ↑ Excellent Improving Compound annual revenue growth over 3 years	22.1% Excellent ↑ Excellent Improving Compound annual revenue growth over 3 years	10.5% Good ↑ Good Improving Compound annual revenue growth over 3 years	-8.4% Weak ↓ Weak Declining Compound annual revenue growth over 3 years	6.4% Fair ↓ Fair Declining Compound annual revenue growth over 3 years	14.5% Good ↓ Good Declining Compound annual revenue growth over 3 years	19.9% Excellent ↑ Excellent Improving Compound annual revenue growth over 3 years	18.2% Excellent ↑ Excellent Improving Compound annual revenue growth over 3 years	12.7% Good → Good Stable Compound annual revenue growth over 3 years	10.7% Good ↓ Good Declining Compound annual revenue growth over 3 years	10.6% Good ↓ Good Declining Compound annual revenue growth over 3 years	16.6% Excellent Excellent Compound annual revenue growth over 3 years	31.9% Excellent Excellent Compound annual revenue growth over 3 years	—	—	—	—
Revenue CAGR 5Y (%)	9.8% Good ↓ Good Declining Compound annual revenue growth over 5 years	12.9% Excellent ↑ Excellent Improving Compound annual revenue growth over 5 years	14.0% Excellent ↑ Excellent Improving Compound annual revenue growth over 5 years	8.7% Good ↓ Good Declining Compound annual revenue growth over 5 years	3.0% Caution ↓ Caution Declining Compound annual revenue growth over 5 years	12.8% Excellent ↓ Excellent Declining Compound annual revenue growth over 5 years	13.2% Excellent ↓ Excellent Declining Compound annual revenue growth over 5 years	16.7% Excellent ↑ Excellent Improving Compound annual revenue growth over 5 years	15.6% Excellent → Excellent Stable Compound annual revenue growth over 5 years	10.9% Good ↓ Good Declining Compound annual revenue growth over 5 years	14.7% Excellent Excellent Compound annual revenue growth over 5 years	23.5% Excellent Excellent Compound annual revenue growth over 5 years	—	—	—	—	—	—
EPS CAGR 3Y (%)	—	—	—	0.0% Caution ↑ Caution Improving Compound annual EPS growth over 3 years	-24.4% Weak ↓ Weak Declining Compound annual EPS growth over 3 years	-11.8% Weak ↓ Weak Declining Compound annual EPS growth over 3 years	-23.9% Weak ↓ Weak Declining Compound annual EPS growth over 3 years	58.7% Excellent ↑ Excellent Improving Compound annual EPS growth over 3 years	-2.7% Weak ↓ Weak Declining Compound annual EPS growth over 3 years	17.4% Excellent Excellent Compound annual EPS growth over 3 years	—	111.8% Excellent Excellent Compound annual EPS growth over 3 years	—	—	—	—	—	—

💰 Are margins durable? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Dec 31, 2009 10-K ↗	FY 2008 Dec 31, 2008 10-K ↗
Operating Margin (%) (%)	—	—	—	—	—	—	—	—	—	22.1% Good → Good Stable Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-26%)	23.2% Good ↑ Good Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-23%)	22.4% Good ↑ Good Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-25%)	20.6% Good ↑ Good Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-31%)	9.9% Caution ↑ Caution Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-67%)	17.2% Fair ↑ Fair Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-43%)	10.6% Caution Caution Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-65%)	-0.9% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-103%)	—
Profit Margin (%) (%)	-20.8% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-183%)	-51.6% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-306%)	-20.7% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-183%)	4.4% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-82%)	12.5% Fair ↓ Fair Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-50%)	7.1% Caution ↓ Caution Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-72%)	4.4% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-83%)	30.7% Excellent ↑ Excellent Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+23%)	10.4% Fair → Fair Stable Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-58%)	10.0% Caution ↑ Caution Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-60%)	8.2% Caution ↑ Caution Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-67%)	12.2% Fair ↑ Fair Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-51%)	7.5% Caution ↑ Caution Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-70%)	-8.2% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-133%)	2.0% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-92%)	-3.9% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-116%)	-19.4% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-177%)	—
FCF Margin (%) (%) N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
FCF / Net Income (x) N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

🎯 Is capital allocation efficient? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Dec 31, 2009 10-K ↗	FY 2008 Dec 31, 2008 10-K ↗
Return on Invested Capital (%) N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Capital (%) (%)	—	—	—	—	—	—	—	—	—	2.7% Weak → Weak Stable Operating profit relative to total assets Optimal: > 10%	3.0% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	2.7% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	2.4% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	1.2% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	2.1% Weak Weak Operating profit relative to total assets Optimal: > 10%	0.9% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—
Return on Common Equity (%) (%)	-5.3% Weak → Weak Stable Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-167%)	-12.5% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-256%)	-4.1% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-151%)	0.5% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-93%)	3.1% Weak → Weak Stable Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-62%)	1.7% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-79%)	0.9% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-89%)	6.6% Caution ↑ Caution Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-18%)	1.9% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-76%)	2.7% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-66%)	2.4% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-70%)	3.1% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-61%)	1.7% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-78%)	-1.9% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-124%)	0.4% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-96%)	-0.5% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-107%)	-2.3% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-129%)	—

⚖️ Is the balance sheet risky? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Dec 31, 2009 10-K ↗	FY 2008 Dec 31, 2008 10-K ↗
Debt to Equity (x)	0.85x Fair ↑ Fair Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-15%)	0.89x Fair ↑ Fair Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-11%)	0.73x Fair ↓ Fair Declining Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-27%)	0.71x Fair ↓ Fair Declining Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-29%)	0.82x Fair → Fair Stable Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-18%)	0.95x Fair ↑ Fair Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: At sector avg	0.82x Fair ↓ Fair Declining Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-18%)	0.78x Fair ↓ Fair Declining Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-22%)	0.85x Fair ↓ Fair Declining Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-15%)	1.05x Caution → Caution Stable Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: At sector avg	1.15x Caution ↑ Caution Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Above avg (+15%)	0.97x Fair ↑ Fair Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: At sector avg	0.88x Fair ↑ Fair Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-12%)	0.83x Fair Fair Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-17%)	0.41x Good Good Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-59%)	—	—	—
Interest Coverage (x) N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Net Debt (USD)	$3.89B	$4.59B	$4.97B	$5.29B	$1.79B	$2.91B	$2.72B	$2.42B	$2.68B	$1.76B	$1.58B	$1.39B	$1.20B	$1.02B	$569.66M	$-29.27M	$-219.00M	$-128.33M
Debt / EBITDA (x) N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

📊 What does each share earn? 8 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Dec 31, 2009 10-K ↗	FY 2008 Dec 31, 2008 10-K ↗
Revenue per Share (USD)	$3.37	$3.47	$3.55	$3.70	$3.75	$3.39	$3.36	$3.38	$3.39	$3.37	$3.20	$3.10	$2.82	$2.67	$2.45	$2.45	$2.30	—
Basic EPS, GAAP (USD)	$-0.71	$-1.81	$-0.74	$0.15	$0.45	$0.24	$0.15	$1.04	$0.35	$0.34	$0.26	$0.38	$0.21	$-0.22	$0.04	$-0.10	$-0.44	—
Free Cash Flow per Share (USD) N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Dividend per Share (USD)	$1.10	$1.24	$1.24	$1.24	$1.21	$1.27	$1.25	$1.23	$1.21	$1.19	$1.17	$1.16	$1.15	$1.27	$1.46	—	—	—
Book Value per Share (USD)	$13.13	$14.93	$17.91	$33.08	$14.52	$14.52	$15.51	$15.86	$16.00	$12.35	$10.94	$12.07	$12.16	$11.26	$14.00	$14.68	$18.99	—
Tangible Book Value per Share (USD)	$13.13	$14.93	$17.25	$32.00	$14.50	$14.52	$15.51	$15.86	$16.00	$12.35	$10.94	$12.07	$12.16	$11.26	$14.00	$14.68	$18.99	—
Basic Weighted Avg Shares (shares)	349.80M	365.55M	378.93M	252.36M	142.64M	218.08M	205.72M	206.06M	181.06M	136.62M	126.07M	119.90M	114.04M	111.36M	111.95M	82.98M	56.41M	—
Dividend Payout Ratio (%)	-154.9% Excellent Excellent Dividends paid as a percentage of earnings Optimal: 30-60%	-68.5% Excellent Excellent Dividends paid as a percentage of earnings Optimal: 30-60%	—	—	—	—	—	—	—	—	450.0% Weak ↑ Weak Improving Dividends paid as a percentage of earnings Optimal: 30-60%	303.9% Weak ↓ Weak Declining Dividends paid as a percentage of earnings Optimal: 30-60%	547.6% Weak ↓ Weak Declining Dividends paid as a percentage of earnings Optimal: 30-60%	-579.1% Excellent Excellent Dividends paid as a percentage of earnings Optimal: 30-60%	3650.0% Weak Weak Dividends paid as a percentage of earnings Optimal: 30-60%	—	—	—

🏦 How resilient is the balance sheet? 2 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Dec 31, 2009 10-K ↗	FY 2008 Dec 31, 2008 10-K ↗
LT Debt (USD)	$3.91B	$4.66B	$4.99B	$5.35B	$1.80B	$3.03B	$2.75B	$2.54B	$2.78B	$1.77B	$1.59B	$1.40B	$1.21B	$1.04B	$639.15M	—	—	—
Total Equity (USD)	$4.62B	$5.23B	$6.82B	$7.57B	$2.19B	$3.17B	$3.36B	$3.26B	$3.28B	$1.69B	$1.38B	$1.45B	$1.39B	$1.25B	$1.57B	$1.49B	$1.07B	$599.32M

📋 What is driving earnings? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Dec 31, 2009 10-K ↗	FY 2008 Dec 31, 2008 10-K ↗
Sales/Revenue/Turnover (USD)	$1.18B	$1.27B	$1.34B	$932.64M	$534.82M	$738.97M	$692.04M	$696.43M	$613.99M	$460.93M	$403.82M	$371.50M	$321.60M	$297.38M	$274.44M	$203.08M	$129.49M	—
Depreciation Expense (USD)	$563.97M	$675.15M	$730.71M	$453.08M	$202.71M	—	—	—	—	—	—	—	—	—	$65.10M	—	—	—
Net Income, GAAP (USD)	$-246.07M	$-654.49M	$-278.26M	$40.90M	$66.66M	$52.62M	$30.15M	$213.46M	$63.92M	$45.91M	$32.93M	$45.37M	$24.26M	$-24.42M	$5.54M	$-7.90M	$-25.08M	—
Operating Cash Flow (USD)	$457.10M	$501.62M	$499.82M	$272.75M	$232.63M	$387.96M	$340.39M	$337.40M	$307.54M	$203.69M	$191.09M	$168.50M	$147.82M	$116.78M	$111.81M	$58.50M	$21.63M	—

🏛️ Sector-Specific 2 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Dec 31, 2009 10-K ↗	FY 2008 Dec 31, 2008 10-K ↗
FFO (approx.) (USD)	$317.89M	$20.67M	$452.45M	$493.98M	$269.37M	$356.45M	$320.54M	$493.09M	$308.90M	$222.78M	$187.06M	$185.80M	$145.91M	$91.07M	$113.08M	$70.66M	$28.52M	—
FFO per Share (approx.) (USD)	$0.91	$0.06	$1.19	$1.96	$1.89	$1.63	$1.56	$2.39	$1.71	$1.63	$1.48	$1.55	$1.28	$0.82	$1.01	$0.85	$0.51	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 18 years · 68 quarters

Healthcare Realty Trust Inc

Analytical Summary

18-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Dividend History

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare HR with peers